Bioprocessing Application Notes & Case Studies
-
ADCs vs. AOCs: Shared Design Principles & Key Differences In Bioconjugate Engineering
9/8/2026
Discover how payload size, charge density, and linker dynamics shape clearance, loading ratios, and intracellular delivery in next-generation oligonucleotide bioconjugates.
-
Accelerating CAR T-Cell Therapy Manufacturing For Autoimmune Disease
9/7/2026
Proactive alignment and integrated quality systems can shorten cell therapy timelines. Rapid tech transfer and in-house analytics support regulatory rigor and reduce scaling risks.
-
Beyond Protein A: Efficient Purification Strategies For Misbehaving mAbs
9/1/2026
Next-generation antibody formats require more precise purification strategies. Explore how subdomain-specific VHH ligands can address structural heterogeneity, improve purity, and preserve stability.
-
Single-Use Clarification Across Process Scales
9/1/2026
Gain insight into how combining centrifugation with targeted depth and chromatographic clarification can reduce filter demand, ease facility constraints, and support efficient mAb harvest.
-
Don't Intensify Blindly: Preventing Fouling And Restoring Performance With Targeted Cleaning Of Protein A Resins
8/27/2026
Protein A chromatography intensification can increase productivity, but it may also affect process robustness. Explore key tradeoffs, operational challenges, and practical considerations.
-
Sterile Filter Membrane Selection For Cell Culture Media Filtration
8/24/2026
Membrane design and filtration capacity affect pressure, throughput, and scale-up. See how comparative testing reveals opportunities to reduce required filtration area, capsule use, and changeouts.
-
Detect Low-Abundance GLP-1 Impurities With Greater Sensitivity
8/24/2026
Low-level impurities can be difficult to resolve using conventional approaches. Discover how a Charged Surface 2.3 µm superficially porous Phenyl-Hexyl column enhances reversed-phase LC-MS analysis.
-
Differentiate Challenging Site-Specific Isomeric Amino Acids
8/24/2026
Learn how high-resolution ion mobility, pre-IMS fragmentation, and product ion analysis can resolve difficult peptide isomers and localize structural differences, supporting confident characterization.
-
Increase Throughput For Intact Mass Confirmation And Impurity Screening
8/24/2026
Accelerate intact mass analysis of GLP-1 analogues with automated purity calculations, sub-ppm mass accuracy, and impurity detection for consistent results in under one minute per sample.
-
Fusion-Enabled Biosimilar Peptide Teriparatide Expression
8/24/2026
See how high-throughput fusion partner screening identified teriparatide production strains exceeding 6 g/L expression, supporting biosimilar comparability assessment and commercial manufacturing readiness.